Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Dental implant showdown: zirconia vs. titanium frameworks tested for durability

NCT ID NCT07657364

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial compares two types of full-arch dental implant frameworks—one made from a single piece of zirconia and the other from titanium with a zirconia top—in people who have lost all teeth in one or both jaws. The goal is to see which material leads to fewer mechanical problems and better quality of life over a year. Participants receive either framework and are monitored for complications like cracks or loosening.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Monolithic zirconia prosthesis or titanium framework with zirconia superstructure
What this could lead to
If successful, this could show that monolithic zirconia frameworks are a durable, less complication-prone option for full-arch dental implants, improving patient quality of life.
What could go wrong
This is a small, early-stage trial with only 12 participants and a 12-month follow-up, so results may not apply broadly. Both materials could show similar complication rates.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 12 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Aged 18 years or older. 2. Able to understand the study procedures and provide written informed consent. 3. In good general health, classified as American Society of Anesthesiologists (ASA) Physical Status Class I or II. 4. Completely edentulous in the arch to be treated (maxilla and/or mandible). 5. A candidate for a full-arch, screw-retained implant-supported prosthesis, requiring 4 to 6 implants in the treatment arch. 6. Sufficient bone volume at planned implant sites to place implants of at least 3.5mm in diameter and 8mm in length. 7. Adequate crown height space (15-22 mm) for a fixed prosthesis. 8. A zone of keratinized mucosa at the crest of the ridge measuring at least 2 mm in width. 9. Opposing arch is fixed full-arch implant-supported prosthesis. 10. Demonstrates acceptable oral hygiene and the motivation to maintain it. Exclusion Criteria: 1. Medical contraindications: * Uncontrolled diabetes (HbA1c \> 7.0%). * History of radiotherapy in the head and neck region. * History of intravenous bisphosphonate therapy. * Immunosuppressed or immunocompromised status. * Any other uncontrolled systemic disease that constitutes a contraindication for oral surgery. 2. Behavioral Factors: * Heavy smoking, defined as consumption of more than 10 cigarettes per day. * Presence of parafunctional habits (e.g., bruxism, clenching) as diagnosed by clinical examination. 3. Local Oral Factors: * Active, untreated periodontal disease in any remaining dentition. * Presence of acute oral infection or pathology at the intended surgical site. * Crown height space less than 15 mm or more than 22 mm. * Insufficient keratinized mucosa (\< 2 mm width) that cannot be corrected with a simple surgical procedure prior to implant placement. 4. General: * Pregnancy or lactation. * Participation in another interventional clinical trial. * Perceived inability to comply with the study protocol and follow-up schedule.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Complete edentulism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Faculty of Dentistry - Cairo University

    RECRUITING

    Cairo, 11553, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.